文献速递生殖医学妇科

多囊卵巢综合征卵泡液与颗粒黄体细胞血管生成潜能改变与黄体缺陷相关

Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome.
PubMed 文献 · Hum Reprod · 2021-01-01

这项病例对照研究纳入30例健康对照和30例接受控制性卵巢过度刺激行IVF的PCOS女性,收集卵泡液、颗粒黄体细胞和血清。结果显示PCOS女性卵泡液和颗粒黄体细胞的促血管生成因子表达降低、诱导血管生成能力减弱,提示其血管生成潜能改变可能参与黄体形成与功能缺陷。

要点

  • PCOS女性卵泡液促血管生成能力下降,VEGF和FGF2水平分别显著升高和降低。
  • PCOS颗粒黄体细胞管形成和Dil-Ac-LDL内化能力显著降低,内皮样特征减弱。
  • 多个血管生成基因转录水平与卵母细胞受精率呈正相关。

核心结论

  • PCOS女性卵泡液和颗粒黄体细胞的促血管生成因子表达降低,诱导血管生成能力减弱,可能影响黄体形成和功能。

研究设计与样本

  • 病例对照研究,纳入30例健康对照女性和30例接受控制性卵巢过度刺激行IVF的PCOS女性,于取卵时收集卵泡液、颗粒黄体细胞和血清。

主要发现

  • PCOS组卵泡液和血清VEGF水平显著高于对照,FGF2水平显著低于对照。
  • PCOS组卵泡液处理后HUVECs管形成和伤口愈合能力较对照降低。
  • PCOS组颗粒黄体细胞管形成(P = 0.003)和Dil-Ac-LDL内化(P = 0.03)能力显著降低。
  • PCOS组颗粒黄体细胞内皮标志物VEGFA(P = 0.004)、VEGFR2(P = 0.011)、Tie-2(P = 0.026)、FGFR1(P = 0.026)和CD31(P = 0.035)蛋白表达降低。
  • PCOS组颗粒黄体细胞血管生成基因VEGFA(P = 0.042)、HIF1A(P = 0.025)、FGF2(P = 0.038)、ANGPT1(P = 0.028)、HSPG2(P = 0.016)、ADAMTS1(P = 0.027)和FN1(P = 0.016)转录水平降低。

临床怎么用

  • PCOS女性卵泡液和颗粒黄体细胞血管生成潜能改变可能参与黄体功能不全,为改善黄体功能和预防流产提供潜在干预靶点。

局限性

  • 无法直接在女性体内研究黄体血管形成,仅通过卵泡液和颗粒黄体细胞推测。
  • 样本来自刺激周期取卵时,可能不完全反映体内生理状态。
  • 样本量较小,需更大样本和彩色多普勒黄体血流研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is angiogenic potential of follicular fluid (FF) and granulosa-lutein cells (GLCs) altered in polycystic ovary syndrome (PCOS) and does it play a role in corpus luteum (CL) defect observed in them? SUMMARY ANSWER: FF and GLCs of women with PCOS show reduced expression of pro-angiogenic factors compared to controls and exhibit a diminished capacity to induce angiogenesis. WHAT IS KNOWN ALREADY: In women with PCOS, CL insufficiency and frequent miscarriage are reported, which may be due to defect in CL. The development of new blood vessels is essential to promote ovarian folliculogenesis and functional CL formation. The vasculature formation in CL which is important for its function is still unexplored in these women. STUDY DESIGN, SIZE, DURATION: This case-control study was conducted in 30 healthy control women and 30 women with PCOS undergoing controlled ovarian hyperstimulation for IVF. The FF, GLCs and serum were collected from all participants during ovum pick up. PARTICIPANTS/MATERIALS, SETTING, METHODS: The capacity of FF to induce angiogenesis was assessed by measuring levels of pro-angiogenic factors vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2) and its tube formation and wound healing potential using human umbilical vein endothelial cells (HUVECs). We investigated the angiogenic potential and endothelial cell-like nature of GLCs using several approaches such as the expression of angiogenic genes by quantitative PCR, DiI-conjugated acetylated low-density lipoproteins (Dil-Ac-LDL) internalization assay, tube formation assay, expression of endothelial cell markers by immunofluorescence analysis. In addition, correlation of transcript levels of angiogenic genes with oocyte parameters was studied. MAIN RESULTS AND THE ROLE OF CHANCE: FF and serum levels of VEGF and FGF2 were significantly higher and lower, respectively, in PCOS compared to controls. The tube formation and wound healing capacity of HUVECs was found to be reduced when measured after supplementation with FF of women with PCOS compared to controls. This suggests a decreased angiogenic capacity of FF in women with PCOS. Tube formation (P = 0.003) and Dil-Ac-LDL internalization (P = 0.03) ability of GLCs were significantly reduced in women with PCOS compared to controls. Protein expression levels of endothelial markers, vascular endothelial growth factor A (VEGFA) (P = 0.004), vascular endothelial growth factor receptor 2 (VEGFR2) (P = 0.011), TEK Receptor Tyrosine Kinase (Tie-2) (P = 0.026), fibroblast growth factor receptor 1 (FGFR1) (P = 0.026) and CD31 (P = 0.035) and transcript levels of angiogenic genes VEGFA (P = 0.042), hypoxia inducing factor 1A (HIF1A) (P = 0.025), FGF2 (P = 0.038), angiopoietin 1 (ANGPT1) (P = 0.028), heparin sulfate proteoglycan 2 (HSPG2) (P = 0.016), ADAM metallopeptidase with thrombospondin type1 motif, 1 (ADAMTS1) (P = 0.027) and fibronectin 1 (FN1) (P = 0.016) were found to be low in GLCs of PCOS compared to controls. Thus, the findings of this study indicate that endothelial cell-like characteristics of GLCs were significantly decreased in PCOS. Furthermore, transcript levels of VEGFA (r = 0.46, P = 0.009), ADAMTS1 (r = 0.55, P = 0.001), FGF2 (r = 0.42, P = 0.022) and ANGPT2 (r = 0.47, P = 0.008) showed a positive correlation with oocyte fertilization rate. LIMITATIONS, REASONS FOR CAUTION: The vasculature formation in CL is not possible to study in women, but we explored the angiogenic characteristics of FF and GLC obtained from women with PCOS to speculate any vascularization defect of CL in these women. The FF and GLCs were obtained from the stimulated cycle during oocyte retrieval, which may not exactly mimic the in-vivo condition. The small sample size is another limitation of this study. Larger sample size and support by color Doppler studies on CL blood flow would help to strengthen our findings. WIDER IMPLICATIONS OF THE FINDINGS: Our findings suggest that the altered angiogenic potential of FF and GLCs may affect vasculature development required for CL formation and function in PCOS. These findings pave the way to devise therapeutic strategies to support angiogenesis process in follicle of women with PCOS, which may improve CL insufficiency, progesterone levels and prevent frequent miscarriages in these women. Furthermore, our study also hypothesizes that the vascularization around the ovarian follicles is also compromised which may lead to the growth arrest of the follicles in PCOS, however, this needs thorough investigations. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Grant BT/PR16524/MED/97/346/2016 from the Department of Biotechnology, Government of India. The authors have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Patil K, Hinduja I, Mukherjee S, et al. Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome. Hum Reprod. 2021. PMID: 33377483. doi:10.1093/humrep/deaa351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。